SEC Form 4 · accession 0001209191-16-115635
AERIE PHARMACEUTICALS INC · AERI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gerald D. Cagle
Director
Period of report
Feb 4, 2015
Accepted (ET)
Apr 26, 2016 · 12:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001337553
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 4, 2015 | P | 500 | $25.60 | A | 4,054 | D | |
| Common Stock | Feb 5, 2015 | P | 500 | $24.54 | A | 4,554 | D | |
| Common Stock | Aug 10, 2015 | P | 100 | $16.31 | A | 4,654 | D | |
| Common Stock | Aug 10, 2015 | P | 100 | $16.345 | A | 4,754 | D | |
| Common Stock | Aug 10, 2015 | P | 100 | $16.35 | A | 4,854 | D | |
| Common Stock | Aug 10, 2015 | P | 846 | $16.39 | A | 5,700 | D | |
| Common Stock | Aug 12, 2015 | P | 500 | $15.4585 | A | 6,200 | D | |
| Common Stock | Aug 28, 2015 | P | 1,524 | $16.60 | A | 7,724 | D | |
| Common Stock | Aug 28, 2015 | P | 476 | $16.5999 | A | 8,200 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
This Form 4 reports delinquent transactions that would have been reportable on February 6, 2015, August 12, 2015 and September 1, 2015.